MIF and in situ carcinoma: These include ISO1 which we have shown to be effective as well as EAE and EAN [27], and/or a potent dual small molecule inhibitor of MIF and DDT [32] that could be of particular interest for diseases characterized by combined dysregulated production of MIF and DDT such as CIS.